Short Interest in Alvotech (NASDAQ:ALVOW) Drops By 16.3%

Alvotech (NASDAQ:ALVOW) saw a significant decline in short interest in the month of February. As of February 13th, there was short interest totaling 1,195 shares, a decline of 16.3% from the January 29th total of 1,428 shares. Based on an average daily volume of 1,208 shares, the short-interest ratio is currently 1.0 days. Based on an average daily volume of 1,208 shares, the short-interest ratio is currently 1.0 days.

Alvotech Price Performance

Shares of ALVOW stock opened at $0.35 on Thursday. Alvotech has a 52-week low of $0.15 and a 52-week high of $3.00. The business has a 50-day simple moving average of $0.49 and a 200-day simple moving average of $0.89.

About Alvotech

Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.

Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.